Ameliora Wealth Management Ltd. Has $2.88 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Ameliora Wealth Management Ltd. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,919 shares of the healthcare conglomerate’s stock after buying an additional 27 shares during the period. UnitedHealth Group comprises 1.2% of Ameliora Wealth Management Ltd.’s holdings, making the stock its 25th largest position. Ameliora Wealth Management Ltd.’s holdings in UnitedHealth Group were worth $2,876,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Able Wealth Management LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $94,000. Wealth Forward LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $667,000. Raleigh Capital Management Inc. boosted its holdings in UnitedHealth Group by 13.0% during the fourth quarter. Raleigh Capital Management Inc. now owns 972 shares of the healthcare conglomerate’s stock worth $512,000 after purchasing an additional 112 shares during the last quarter. Napa Wealth Management bought a new stake in UnitedHealth Group in the fourth quarter worth about $2,495,000. Finally, Proathlete Wealth Management LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $881,000. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 0.1 %

UnitedHealth Group stock traded up $0.35 during trading hours on Friday, hitting $598.05. The stock had a trading volume of 1,909,733 shares, compared to its average volume of 2,855,968. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $552.25 billion, a P/E ratio of 39.66, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The stock’s 50-day moving average price is $583.64 and its 200-day moving average price is $531.08.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the previous year, the company earned $6.14 earnings per share. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on UNH shares. TD Cowen upped their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday. They issued an “overweight” rating and a $675.00 price objective for the company. HSBC upped their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Argus increased their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $617.37.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.